340B Drug Pricing Program
The House Energy and Commerce Oversight and Investigations subcommittee today hosted a hearing to discuss oversight of the 340B Drug Pricing Program.
AHA expresses strong support for the 340B program and urges Congress to protect this critical program as it has done for more than three decades.
AHA 340B Advocacy Alliance Bulletin for May 30, 2024.
The House Energy and Commerce Committee Subcommittee on Oversight and Investigations (O&I) June 4 will host a hearing titled, “Oversight of 340B Drug Pricing Program.” Please contact your Energy and Commerce member before the June 4 hearing and share with them the importance of the 340B program…
AHA 340B Advocacy Alliance Bulletin for May 21,2024.
The Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) April 19 published the 340B Administrative Dispute Resolution (ADR) final rule establishing a process that was required under the Affordable Care Act.
The Department of Health and Human Services April 18 finalized its rule to establish a 340B Administrative Dispute Resolution process as required under the Affordable Care Act.
The Administration’s final rule for the 340B drug pricing program administrative dispute resolution (ADR) process is an important step in ensuring the integrity of the 340B program. The final rule contains several important process improvements, including a clear timeline for when ADR decisions…
Sen. John Thune, R-S.D., April 16 updated AHA members on progress to extend telehealth waivers, offering hope that a solution will arise in end-of-year legislation that Congress will attempt to pass.
Get access to the 340B Access Act and learn how it can protect and clarify the 340B program. Stay informed with the latest updates and advocacy efforts.